NCT04673513

Brief Summary

The purpose of this study is to compare two psychological treatments for major depressive disorder (MDD): cognitive-behavioral therapy (CBT) and CBT-Skill Enhanced (CBT-SE). CBT is well-studied, research-supported treatment for depression. CBT-SE is a variant of CBT that places greater focus on helping clients to developing the skills of CBT. The study will enroll 150 participants with MDD. Participants will be randomized to CBT or CBT-SE, with 75 participants being assigned to each condition. For both conditions, treatment will be provided over 12 weeks, with a 6 month follow-up period. Potential participants are asked to complete an initial screening and an intake evaluation to determine eligibility. After entering the study, participants are asked to complete evaluations at 4 weeks and at 12 weeks. They are also asked to respond to self-report instruments before and after each session. Following the 12 week treatment, participants are asked to complete monthly follow-up surveys for 6 months. The primary objectives of this study are three-fold. The first is to compare the outcomes of the two treatments. The second is to evaluate potential mediators of any treatment differences. The third is to evaluate the process of change in these two versions of CBT.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for not_applicable depression

Timeline
Completed

Started Dec 2020

Typical duration for not_applicable depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 11, 2020

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

December 12, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 17, 2020

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 8, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 19, 2023

Completed
Last Updated

April 18, 2024

Status Verified

April 1, 2024

Enrollment Period

1.9 years

First QC Date

December 12, 2020

Last Update Submit

April 17, 2024

Conditions

Keywords

Cognitive Behavioral TherapyDepressionRandomized Clinical TrialCognitive Behavioral Skills

Outcome Measures

Primary Outcomes (4)

  • Change in Quick Inventory of Depressive Symptoms-Self-Report at week 12.

    The Quick Inventory of Depressive Symptoms-Self-Report is a 16-item self-report measure of depressive symptoms. Scores range from 0 to 27, with higher scores indicating greater depressive symptoms.

    Weeks 0-12, assessments occurred at every session through week 12.

  • Change in Cognitive Change Sustained at week 12.

    The Cognitive Change Sustained is a 9-item measure designed to assess the degree to which experienced cognitive change and used cognitive and behavioral strategies in the days leading up to their session. Scores range from 0 to 54, with a higher score indicating greater cognitive change.

    Weeks 0-12, assessments occurred at every session aside from session 1 through week 12.

  • Change in Ways of Responding Scale at week 12.

    The Ways of Responding Scale is a measure of the skills taught in CBT for depression. Participants respond to 6 hypothetical stressful situations in which their initial thoughts regarding the event are given. Quality scores range from 0 to 6, with a higher score indicating greater CBT skills.

    Weeks 0-12, assessments occurred at intake, week 4, and week 12.

  • Change in CBT Skills - Interview at week 12.

    The CBT skills interview is a semi-structured interview based measure of CBT skills. Assessors evaluate the clients CBT skills use over the past two weeks with seven items. This interview assesses client skills in using coping strategies central to CBT. Scores range from 0 to 28, with a higher score indicating greater CBT skills.

    Weeks 0-12, assessments occurred at intake, week 4, and week 12.

Secondary Outcomes (5)

  • Change in Quick Inventory of Depressive Symptoms-Clinician version at week 12.

    Weeks 0-12, assessments occurred at intake, week 4, and week 12.

  • Change in Cognitive Change Immediate at week 12.

    Weeks 0-12, assessments occurred at every session through week 12.

  • Change in Competencies of Cognitive Therapy Scale - client version at week 12.

    Weeks 0-12, assessments occurred at intake, week 4, and week 12.

  • Change in Competencies of Cognitive Therapy Scale - therapist version at week 12.

    Weeks 0-12, assessments occurred at intake, week 4, and week 12.

  • Change in Work Social Adjustment Scale at week 12.

    Weeks 0-12, assessments occurred at intake, week 4, and week 12.

Other Outcomes (1)

  • Time to relapse per modified version of the Patient Health Questionnaire

    Immediately post-treatment to 6 months post treatment. Assessments occurred monthly following the posttreatment evaluation

Study Arms (2)

Cognitive Behavioral Therapy (CBT)

ACTIVE COMPARATOR

Cognitive behavioral therapy will be provided as described in Beck et al. (1979) and Beck (2011), with adaptations for the treatment of comorbid personality disorders as described in Beck et al. (2015).

Other: Psychotherapy

Cognitive Behavioral Therapy - Skill enhanced (CBT-SE)

ACTIVE COMPARATOR

This condition includes a variation of CBT (as provided in the other condition) with special emphasis on helping clients to develop the skills of CBT.

Other: Psychotherapy

Interventions

In light of COVID-19 considerations, interventions are currently being provided via telehealth technology.

Cognitive Behavioral Therapy (CBT)Cognitive Behavioral Therapy - Skill enhanced (CBT-SE)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of major depressive disorder (MDD) according to DSM-5 criteria;
  • years old or older;
  • residence in the state of Ohio;
  • access to a reliable internet connection (to participate in virtual sessions); and
  • being able and willing to give informed consent.

You may not qualify if:

  • current or past diagnosis of bipolar disorder or a psychotic disorder;
  • moderate or severe substance use in the past 6 months (where "moderate" is defined as 4-5 symptoms and "severe" is defined as 6 + symptoms of those listed in DSM-5 for each of the substance-related disorders);
  • current disorder other than MDD if it constitutes the predominant aspect of the clinical presentation and if it requires treatment other than that being offered;
  • currently participating in a treatment for an emotional disorder, including any individual psychotherapy or psychiatric medications used to treat a mood or anxiety disorders;
  • clear indication of secondary gain (e.g., court-ordered treatment); and
  • current suicide risk or significant intentional self-harm in the last six months sufficient to preclude treatment on an outpatient basis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Psychology, The Ohio State University

Columbus, Ohio, 43210, United States

Location

Related Publications (1)

  • Beck AT, Rush AJ, Shaw BF, Emery G. (1979). Cognitive Therapy of Depression. Guilford.

    BACKGROUND

MeSH Terms

Conditions

Depression

Interventions

Psychotherapy

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Behavioral Disciplines and Activities

Study Officials

  • Daniel R Strunk, PhD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 12, 2020

First Posted

December 17, 2020

Study Start

December 11, 2020

Primary Completion

November 8, 2022

Study Completion

April 19, 2023

Last Updated

April 18, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

We will consider requests for data sharing, pending approval from our IRB.

Locations